Showing results (151-160 of 6,708) with videos related to

Sort By:
Pageof 671
Oncotargets and Therapy|May 24, 2019
KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNAXiaoyu Cheng, Ming Li, Xi Rao, et al.
Oncotargets and Therapy|April 15, 2022
An Innovative Site-Specific Anti-HER2 Antibody-Drug Conjugate with High Homogeneity and Improved Therapeutic IndexXiwu Hui, Can Yuan, Weirong Cao, et al.
Oncotargets and Therapy|April 15, 2022
Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to AfatinibScott Owen, Scheryll Alken, Jad Alshami, et al.
Oncotargets and Therapy|March 21, 2022
Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma PatientsMichel Delforge, Jolien Raddoux, Corine Antonis, et al.
Oncotargets and Therapy|March 22, 2022
A Novel LOC101927967 Intergenic Region ALK Fusion Identified by NGS and Validated by IHC and FISH in a Patient with Early Stage Adenocarcinoma of LungXiaojing Jia, Qianru He, Xiaodan Xing, et al.
Oncotargets and Therapy|October 22, 2021
MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction]
Oncotargets and Therapy|October 22, 2021
Clinical Significance of ADAMTS19, BMP7, SIM1, and SFRP1 Promoter Methylation in Renal Clear Cell CarcinomaRaimonda Kubiliute, Algirdas Zalimas, Arnas Bakavicius, et al.
Oncotargets and Therapy|October 22, 2021
MicroRNA-937 Inhibits the Malignant Phenotypes of Breast Cancer by Directly Targeting and Downregulating Forkhead Box Q1 [Retraction]
Oncotargets and Therapy|October 22, 2021
MicroRNA-675 Directly Targets MAPK1 to Suppress the Oncogenicity of Papillary Thyroid Cancer and is Sponged by Long Non-Coding RNA RMRP [Retraction]
Oncotargets and Therapy|October 22, 2021
Correlation Between Thymoma and Soluble Interleukin-2 Receptor Expression in a Patient with Good SyndromeHaruka Kitano, Fumihiro Yamaguchi, Kenji Atarashi, et al.
Pageof 671